Molecular Stethoscope Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $4.49M
Latest Deal Amount
  • Investors
  • 4

Molecular Stethoscope General Information

Description

Developer of disease monitoring technology intended to obtain genetic information through novel blood-based early test detection. The company's technology is based on molecular diagnostics engaged in transcriptomic research and development that analyzes tissue-specific cell-free circulating RNA in a blood sample to monitor organ damage, enabling physicians to transform healthcare by providing early insight into a patient's healthy versus disease state and reduces healthcare costs.

Contact Information

Website
www.molecularstethoscope.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Biotechnology
Primary Office
  • 10835 Road to the Cure
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Stethoscope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 04-Oct-2019 $4.49M 000.00 000.00 Completed Generating Revenue
2. Seed Round 05-Jan-2017 00.00 00.00 000.00 Completed Startup
1. Seed Round 21-Oct-2015 Completed Startup
To view Molecular Stethoscope’s complete valuation and funding history, request access »

Molecular Stethoscope Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Molecular Stethoscope’s complete cap table history, request access »

Molecular Stethoscope Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease monitoring technology intended to obtain genetic information through novel blood-based early test d
Monitoring Equipment
San Diego, CA
11 As of 2016
000.00
00.00 0000-00-00
000000000 000.00

0000000

m dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000000
Waltham, MA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat n
0000000000000
Richmond Hill, Canada
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Molecular Stethoscope Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exosome Diagnostics Formerly VC-backed Waltham, MA 00 00000 000000&0 00000
000000 Venture Capital-Backed Richmond Hill, Canada 00 000.00 000000 - 000 000.00
00000000 00 Venture Capital-Backed Thousand Oaks, CA 0 000.00 0000000000 0 000.00
000000000 00000000 Venture Capital-Backed Tolochenaz, Switzerland 00 000.00 00000000000 000.00
000000000000 Formerly VC-backed Carlsbad, CA 000 000.00 000000&0 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Molecular Stethoscope Executive Team (8)

Name Title Board Seat Contact Info
Tina Nova Ph.D Co-Chief Executive Officer, President and Board Member
Guillermo Elias Co-Chief Executive Officer
Stephen Quake Ph.D Co-Founder & Board Member
Eric Topol MD Co-Founder & Board Member
You’re viewing 4 of 8 executive team members. Get the full list »

Molecular Stethoscope Board Members (3)

Name Representing Role Since
Arda Minocherhomjee Ph.D Self Board Member 000 0000
Eric Topol MD Self Co-Founder & Board Member 000 0000
Stephen Quake Ph.D Molecular Stethoscope Co-Founder & Board Member 000 0000
To view Molecular Stethoscope’s complete board members history, request access »

Molecular Stethoscope Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molecular Stethoscope Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arab Angel Venture Capital Minority 000 0000 000000 0
Index Ventures Venture Capital Minority 000 0000 000000 0
Pfizer Corporation Minority 000 0000 000000 0
Data Collective Venture Capital Minority 000 0000 000000 0
To view Molecular Stethoscope’s complete investors history, request access »

Ready to get started?

Request a free trial